Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2003
04/19/2003CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031459A2 Modulation of the expression of genes dependent on stat-1
04/17/2003WO2003031447A2 Pyrimidine derivatives
04/17/2003WO2003031445A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003WO2003030947A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
04/17/2003WO2003030944A2 Inhibition of stat-1
04/17/2003WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003WO2003030939A1 Therapies for treating respiratory diseases
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003WO2003030920A1 An antispasmodic agent spaced drug delivery system
04/17/2003WO2003030919A1 Method of obtaining an extract of ginger
04/17/2003WO2003030912A1 Prostaglandin analogs as chloride channel opener
04/17/2003WO2003030905A1 Dihydroorotate dehydrogenase inhibitor
04/17/2003WO2003030904A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003030883A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003WO2003030877A1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer
04/17/2003WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003WO2003030833A2 Angiopoietin-2 specific binding agents
04/17/2003WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders
04/17/2003WO2003008457A3 Polysaccharidic esters of retinoic acid
04/17/2003WO2003007922A3 Pharmaceutical formulation containing an ltb4 antagonist
04/17/2003WO2003005999A3 Methods of treating cytokine mediated diseases
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof
04/17/2003WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
04/17/2003WO2002079221A3 Sapogenin derivatives, their synthesis and use
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof
04/17/2003WO2002069902A3 Cyclosporins for the treatment of respiratory diseases
04/17/2003WO2002050289A9 Methods for the production of multimeric proteins, and related compositions
04/17/2003WO2002050284A3 Oxidoreductases
04/17/2003WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018575A3 Genes expressed in the cell cycle
04/17/2003WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
04/17/2003WO2002012341A3 Her-2/neu fusion proteins
04/17/2003US20030073846 Aminoalcohol derivatives
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073825 Azalide antibiotic compositions
04/17/2003US20030073732 Antiinflammatory agents
04/17/2003US20030073727 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073698 Nitrogen-based camptothecin derivatives
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073690 Controlling pain in mammals
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/17/2003US20030073676 Dissolving in aqueous carrier; antiallergens
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
04/17/2003US20030073625 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073148 Antibodies binding to human airway trypsin-like protease and methods for utilizing the same
04/17/2003US20030073142 Immunoglobulin E vaccines and methods of use thereof
04/17/2003US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening
04/17/2003CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003CA2464662A1 Modulation of the expression of genes dependent on stat-1
04/17/2003CA2463496A1 Method of obtaining an extract of ginger
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2462806A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
04/17/2003CA2462801A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2461435A1 Angiopoietin-2 specific binding agents
04/17/2003CA2461064A1 Inhibition of stat-1
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/16/2003EP1302458A1 Ester derivatives
04/16/2003EP1302201A1 Pharmaceutical composition improved in peroral absorbability
04/16/2003EP1302115A1 Use of cystathionine
04/16/2003EP1301602A2 Fh-binding protein of streptococcus pneumoniae
04/16/2003EP1301598A2 Cell cycle proteins and mitosis-associated molecules
04/16/2003EP1301595A2 G-protein coupled receptors
04/16/2003EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
04/16/2003EP1301535A2 G-protein coupled receptors
04/16/2003EP1301530A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 878